sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 1345.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 28-Feb-2017
WSU looks for practices to thwart antimicrobial resistance
Washington State University scientists are addressing growing global concern about the spread of antimicrobial resistance in Africa. Their work identifying practices that lead to bacterial transmission could help save African lives and prevent the spread of antibiotic resistant bacteria to the US and other parts of the globe.
National Science Foundation, Ecology and Evolution of Infectious Disease Program

Contact: Robert Quinlan
Washington State University

Public Release: 28-Feb-2017
Open Science Prize goes to software tool for tracking viral outbreaks
After three rounds of competition -- one of which involved a public vote -- a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.
National Institutes of Health, Wellcome Trust

Contact: Claire Hudson
Fred Hutchinson Cancer Research Center

Public Release: 28-Feb-2017
Journal of the American Medical Association
Type 2 diabetes diagnosis in youth leads to increased health complications
A new report published in the Feb. 28 issue of the Journal of the American Medical Association points to a significantly higher burden of diabetes-related complications in adolescents and young adults with type 2 diabetes compared to type 1 diabetes, with greater health complications in minority youth.

Contact: Nathan Gill
University of Colorado Anschutz Medical Campus

Public Release: 27-Feb-2017
Science Diplomacy and Policy Conference with Focus on the Americas
Science builds bridges, not walls, diplomacy experts tell UA audience
From eradicating weapons of mass destruction to the scourge of malaria, the speakers at a recent University of Arizona conference -- including a Nobel laureate, ambassadors and advisers to secretaries of state -- know firsthand how science can build trust where politics cannot.

Contact: Jill Goetz
University of Arizona College of Engineering

Public Release: 27-Feb-2017
Disease Models & Mechanisms
Novel syndrome highlights the importance of rare disease research
Tuesday, Feb. 28, 2017, is Rare Disease Day, and this year's slogan is 'With research, possibilities are limitless.' Disease Models & Mechanisms is marking the day by spotlighting a recent paper on a newly discovered deafness-dystonia syndrome documented in a family from Pakistan.
Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Deutsche Forschungsgemeinschaft, Higher Education Commission Pakistan, Association Belge contre les Maladies Neuro-Musculaires, European Union Seventh Framework Programme, Fonds Wetenschappelijk Ond

Contact: Derah Saward-Arav
The Company of Biologists

Public Release: 24-Feb-2017
PLOS Pathogens
Penn vet team identifies new therapeutic targets for tropical disease leishmaniasis
Each year, about 2 million people contract leishmaniasis, which results in disfiguring skin ulcers that may take months or years to heal and in rare cases can become metastatic, causing major tissue damage. Now a team led by University of Pennsylvania School of Veterinary Medicine researchers have a promising target for treatment.
National Institutes of Health

Contact: Katherine Unger Baillie
University of Pennsylvania

Public Release: 23-Feb-2017
Global vaccine injury system needed to improve public health
In an article published in the Journal of the American Medical Association, Sam Halabi, University of Missouri associate professor of law, argues that a global vaccine injury compensation system administered through the World Health Organization would address the global public health issue of vaccine injuries.

Contact: Liz McCune
University of Missouri-Columbia

Public Release: 23-Feb-2017
European Heart Journal
ESC on eHealth revolution: A new vision for cardiovascular medicine
How are smartphones and computer programs transforming healthcare, especially when it comes to preventing, diagnosing and treating heart disease? That's the focus of a collection of articles published today in the European Heart Journal (EHJ).

Contact: ESC Press Office
European Society of Cardiology

Public Release: 23-Feb-2017
European Journal of Pain
Is back pain killing us?
Older people who suffer from back pain have a 13 per cent increased risk of dying from any cause, University of Sydney research has found. Published in the European Journal of Pain, the study of 4390 Danish twins aged more than 70 years investigated whether spinal pain increased the rate of all-cause and disease-specific cardiovascular mortality.

Contact: Kobi Print
University of Sydney

Public Release: 23-Feb-2017
Nature Communications
Scientists close in on cracking 'Enigma Code' of common cold
Scientists at the Universities of York, Leeds, and Helsinki say they are a step closer to cracking, what researchers have dubbed, the 'enigma code' of the common cold virus.
Wellcome Trust

Contact: Samantha Martin
University of York

Public Release: 22-Feb-2017
Proceedings of the National Academy of Sciences
Researchers aim to disrupt egg production in dengue- and Zika-spreading mosquito
The mosquito Aedes aegypti, which can spread dengue fever, chikungunya, Zika fever, and yellow fever virus, requires a blood meal to develop eggs. One way to control the spread of these diseases is to tamper with the reproductive events that follow this mosquito's blood meal. A team of scientists at the University of California, Riverside has explored this at the molecular level. They focused on microRNAs, which play a critical role in mosquito egg maturation.
National Institutes of Health

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 22-Feb-2017
'Smart' bacteria remodel their genes to infect our intestines
How pathogens establish themselves in our gut is poorly understood. Now, researchers have described how bacteria sense their host and tailor their gene expression to cause disease. These findings may lead to the development of new strategies to combat bacterial infection.
Israel Academy of Sciences and Humanities, Carol and Leonard Berall Endowment

Contact: Dov Smith
The Hebrew University of Jerusalem

Public Release: 22-Feb-2017
PLOS Neglected Tropical Diseases
Enormous promise for new parasitic infection treatment
The human whipworm, which infects 500 million people and can damage physical and mental growth, is killed at egg and adult stage by a new drug class developed at the Universities of Manchester and Oxford and University College London.
Biotechnology and Biological Sciences Research Council

Contact: Jamie Brown
University of Manchester

Public Release: 22-Feb-2017
New England Journal of Medicine
First detection of an artemisinin-resistant malaria parasite contracted in Africa
KAUST scientists confirm the African origin of a new strain of malaria parasites resistant to the antimalarial drug artemisinin.

Contact: Michelle D'Antoni
King Abdullah University of Science & Technology (KAUST)

Public Release: 22-Feb-2017
Device will rapidly, accurately and inexpensively detect the Zika virus at airports
About the size of a tablet, a portable device that could be used in a host of environments like a busy airport or even a remote location in South America, may hold the key to detecting the dreaded Zika virus accurately, rapidly and inexpensively using just a saliva sample. For about $2 and within 15 minutes, researchers hope to accurately determine whether or not an individual has an active infection.
Florida Department of Health

Contact: Gisele Galoustian
Florida Atlantic University

Public Release: 22-Feb-2017
MIT undertakes grand challenge for innovation in global vaccine manufacturing
The Bill & Melinda Gates Foundation has awarded a $17.6 million Grand Challenge grant to the Massachusetts Institute of Technology, University College London, and Kansas University to pursue an innovative research project for global health to create a next-generation manufacturing platform to produce certain vaccines for less than 15 cents a dose. 'Ultra-low cost, Transferable Automated (ULTRA) Platform for Vaccine Manufacture,' aims to standardize the manufacturing development and production of new protein-based vaccines at globally affordable costs.
Bill and Melinda Gates Foundation

Contact: Michael Patrick Rutter
Massachusetts Institute of Technology

Public Release: 21-Feb-2017
International Journal of Infectious Diseases
Risk of Ross River Virus global epidemic
Australia's Ross River Virus (RRV) could be the next mosquito-borne global epidemic according to a new research study led by the University of Adelaide and The Australian National University.

Contact: Philip Weinstein
University of Adelaide

Public Release: 21-Feb-2017
New book on malaria from Cold Spring Harbor Laboratory Press
Written and edited by experts in the field, 'Malaria: Biology in the Era of Eradication,' from Cold Spring Harbor Laboratory Press, explores recent developments in our understanding of malaria biology and their potential to influence malaria elimination/eradication strategies. The authors describe recent developments in their respective research areas and suggest both how these insights could guide intervention strategy and where critical knowledge gaps remain.

Contact: Robert Redmond
Cold Spring Harbor Laboratory

Public Release: 21-Feb-2017
NIH begins study of vaccine to protect against mosquito-borne diseases
The National Institute of Allergy and Infectious Diseases, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections. The study, conducted at the NIH Clinical Center in Bethesda, Maryland, will examine the vaccine's safety and ability to generate an immune response.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Feb-2017
Proceedings of the National Academy of Sciences
Experimental malaria vaccine offers durable protection against many strains in NIH trial
An investigational malaria vaccine has protected a small number of healthy US adults from infection with a malaria strain different from that contained in the vaccine, according to a study published today in the Proceedings of the National Academy of Sciences (PNAS). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored and co-conducted the Phase 1 clinical trial.
NIH/National institute of Allergy and Infectious Diseases

Contact: Elizabeth Deatrick
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Feb-2017
$420,000 grant funds study on polio-like virus
Haoquan Wu, Ph.D., has received a two-year, $420,000 grant from the National Institute of Allergy and Infectious Disease (NIAID) to study Enterovirus 71 (EV71), a relatively new virus that has been compared to polio.
NIH/National Institute of Allergy and Infectious Disease

Contact: Sergio Ramirez
Texas Tech University Health Sciences Center El Paso

Public Release: 21-Feb-2017
Research teams hone in on Zika vaccines, but challenges remain
Public health officials warn that spring's warmer temperatures may herald another increase of Zika virus infections in the Americas. Researchers around the world are racing to develop safe and effective measures to prevent the disease. In a review paper in the journal Immunity, a group of leading vaccine scientists - including Dan H. Barouch, MD, PhD, of BIDMC - outline advances in the hunt for a Zika vaccine and the challenges that still lie ahead.
US Military Research and Material Command, US Military HIV Research Program, National Institutes of Health, Ragon Institute of MGH, MIT, and Harvard

Contact: Jacqueline Mitchell
Beth Israel Deaconess Medical Center

Public Release: 21-Feb-2017
Nature Communications
Zika may cause miscarriages, thin brain tissue in babies carried to term
Johns Hopkins researchers say that in early pregnancy in mice with complete immune systems, Zika virus can cross the placenta -- intended to protect the developing fetus -- and appears to lead to a high percentage of miscarriages and to babies born with thin brain tissue and inflammation in brain cells.
Johns Hopkins Bloomberg School of Public Health, Society for Women's Health Research, Integrated Research Center for Fetal Medicine, Sheikh Abdullah Bugshan Fund

Contact: Barbara Benham
Johns Hopkins University Bloomberg School of Public Health

Public Release: 21-Feb-2017
PLoS Medicine
Modern housing associated with reduced malaria risk in sub-Saharan Africa
Modern houses -- with metal roofs and finished walls -- are associated with a more than 9 percent reduction in the odds of malaria in children in sub-Saharan Africa when compared to more traditional thatched houses, according to a study published in PLOS Medicine by Lucy Tusting of the University of Oxford, UK, and colleagues at the London School of Hygiene & Tropical Medicine, UK, Durham University, UK, and the University of Southampton, UK.

Contact: Lucy S. Tusting

Public Release: 20-Feb-2017
Journal of Global Oncology
New approach to cervical cancer care in Botswana cuts treatment lag time in half
Cervical cancer is the leading cause of cancer deaths for women low- and middle-income countries, including Botswana, where 75 percent of cervical cancer patients suffer from advanced forms of the disease. These patients can face wait times as long as five months after diagnosis before receiving lifesaving treatment. A new, multidisciplinary model of cervical cancer care developed by a University of Pennsylvania team based in Botswana cut the delay between diagnosis and treatment by more than 50 percent.

Contact: Johanna Harvey
University of Pennsylvania School of Medicine

Showing releases 226-250 out of 1345.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>